Correction: PDGFRα depletion attenuates glioblastoma stem cells features by modulation of STAT3, RB1 and multiple oncogenic signals

Carlo Cenciarelli; Hany E. Marei; Armando Felsani; Patrizia Casalbore; Gigliola Sica; Maria Ausiliatrice Puglisi; Angus J.M. Cameron; Alessandro Olivi; Annunziato Mangiola

doi:10.18632/oncotarget.18268

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Corrections:

Correction: PDGFRα depletion attenuates glioblastoma stem cells features by modulation of STAT3, RB1 and multiple oncogenic signals

Carlo Cenciarelli _, Hany E. Marei, Armando Felsani, Patrizia Casalbore, Gigliola Sica, Maria Ausiliatrice Puglisi, Angus J.M. Cameron, Alessandro Olivi and Annunziato Mangiola

PDF | How to cite

Oncotarget. 2017; 8:36931-36931. https://doi.org/10.18632/oncotarget.18268

Metrics: PDF 1926 views | ?

Present: Reference and callout information were presented incorrectly for reference 24.

Correct: The proper reference and callout information are listed below.

RESULTS

Cancer stem cells from GBM were isolated as described previously [24]. We were able to collect either core- (c-CSC) or peritumor tissue-derived cancer stem cells (p-CSC) from several primary GBM samples. The two types of CSC form intracranial tumors in immunocompromised mice. Nevertheless, c-CSC showed a higher tumor initiating ability when compared with p-CSC which had a lower tumorigenicity [24].

REFERENCES

24. Lama G, Mangiola A, Proietti G, Colabianchi A, Angelucci C, D' Alessio A, De Bonis P, Geloso MC, Lauriola L, Binda E, Biamonte F, Giu rida MG, Vescovi A, Sica G. Progenitor/Stem Cell Markers in Brain Adjacent to Glioblastoma: GD3 Ganglioside and NG2 Proteoglycan Expression. J Neuropathol Exp Neurol. 2016; 75:134-47.

Original article: Oncotarget. 2016; 7:53047-63. DOI: 10.18632/oncotarget.10132.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 18268

Publication Alerts

Corrections:

Correction: PDGFRα depletion attenuates glioblastoma stem cells features by modulation of STAT3, RB1 and multiple oncogenic signals